, Volume 233, Issue 3, pp 381–392 | Cite as

Immediate and lasting effects of chronic daily methamphetamine exposure on activation of cells in hypothalamic-pituitary-adrenal axis-associated brain regions

  • Damian G. Zuloaga
  • Lance A. Johnson
  • Sydney Weber
  • Jacob Raber
Original Investigation



Chronic methamphetamine (MA) abuse leads to dependence and symptoms of withdrawal after use has ceased. Negative mood states associated with withdrawal, as well as drug reinstatement, have been linked to drug-induced disruption of the hypothalamic-pituitary-adrenal (HPA) axis. However, effects of chronic MA exposure or acute MA exposure following withdrawal on neural activation patterns within brain regions that regulate the HPA axis are unknown.


In this study, neural activation patterns were assessed by quantification of c-Fos protein in mice exposed to different regimens of MA administration.


(Experiment 1) Adult male mice were treated with MA (5 mg/kg) or saline once or once daily for 10 days. (Experiment 2) Mice were treated with MA or saline once daily for 10 days and following a 10-day withdrawal period were re-administered a final dose of MA or saline. c-Fos was quantified in brains after the final injection.


(Experiment 1) Compared to exposure to a single dose of MA (5 mg/kg), chronic MA exposure decreased the number of c-Fos expressing cells in the paraventricular hypothalamus, dorsomedial hypothalamus, central amygdala, basolateral amygdala, bed nucleus of the stria terminalis (BNST), and CA3 hippocampal region. (Experiment 2) Compared to mice receiving their first dose of MA, mice chronically treated with MA, withdrawn, and re-administered MA, showed decreased c-Fos expressing cells within the central and basolateral amygdala, BNST, and CA3.


HPA axis-associated amygdala, extended amygdala, and hippocampal regions endure lasting effects following chronic MA exposure and therefore may be linked to stress-related withdrawal symptoms.


Glucocorticoid HPA Axis Methamphetamine 


  1. Acevedo SF, Pfankuch T, van Meer P, Raber J (2008) Role of histamine in short- and long-term effects of methamphetamine on the developing mouse brain. J Neurochem 107:976–986PubMedPubMedCentralGoogle Scholar
  2. Armario A, Hidalgo J, Giralt M (1988) Evidence that the pituitary adrenal axis does not cross-adapt to stressors: comparison to other physiological variables. Neuroendocrinology 47:263–267PubMedCrossRefGoogle Scholar
  3. Armario A, Vallès A, Dal-Zotto S, Márquez C, Belda X (2004) A single exposure to severe stressors causes long-term desensitisation of the physiological response to the homotypic stressor. Stress 7:157–172PubMedCrossRefGoogle Scholar
  4. Belda X, Márquez C, Armario A (2004) Long-term effects of a single exposure to stress in adult rats on behavior and hypothalamic-pituitary-adrenal responsiveness: comparison of two outbred rat strains. Behav Brain Res 154:399–408PubMedCrossRefGoogle Scholar
  5. Bhatnagar S, Dallman M (1998) Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience 84:1025–1039PubMedCrossRefGoogle Scholar
  6. Buffalari DM, Baldwin CK, Feltenstein MW, See RE (2012) Corticotrophin releasing factor (CRF) induced reinstatement of cocaine seeking in male and female rats. Physiol Behav 105:209–214PubMedPubMedCentralCrossRefGoogle Scholar
  7. Carson DS, Bosanquet DP, Carter CS, Pournajafi-Nazarloo H, Blaszczynski A, McGregor IS (2012) Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users. Exp Clin Psychopharmacol 20:497–503PubMedCrossRefGoogle Scholar
  8. Chen Y, Bender RA, Frotscher M, Baram TZ (2001) Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J Neurosci 21:7171–7181PubMedPubMedCentralGoogle Scholar
  9. Cornish JL, Hunt GE, Robins L, McGregor IS (2012) Regional c-Fos and FosB/ΔFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats. Neuroscience 206:100–114PubMedCrossRefGoogle Scholar
  10. Danaceau JP, Deering CE, Day JE, Smeal SJ, Johnson-Davis KL, Fleckenstein AE, Wilkins DG (2007) Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur J Pharmacol 559:46–54PubMedCrossRefGoogle Scholar
  11. Fernández-Guasti A, Fiedler JL, Herrera L, Handa RJ (2012) Sex, stress, and mood disorders: at the intersection of adrenal and gonadal hormones. Horm Metab Res 44:607–618PubMedPubMedCentralCrossRefGoogle Scholar
  12. Franklin, KBJ, Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: AcademicPress.Google Scholar
  13. Giardino WJ, Pastor R, Anacker AM, Spangler E, Cote DM, Li J, Stenzel-Poore MP, Phillips TJ, Ryabinin AE (2011) Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine. Genes Brain Behav 10:78–89PubMedPubMedCentralCrossRefGoogle Scholar
  14. Girotti M, Pace TW, Gaylord RI, Rubin BA, Herman JP, Spencer RL (2006) Habituation to repeated restraint stress is associated with lack of stress-induced c-fos expression in primary sensory processing areas of the rat brain. Neuroscience 138:1067–1081PubMedCrossRefGoogle Scholar
  15. Goel N, Bale TL (2010) Sex differences in the serotonergic influence on the hypothalamic-pituitary-adrenal stress axis. Endocrinology 151(4):1784–1794PubMedPubMedCentralCrossRefGoogle Scholar
  16. Graybiel AM, Moratalla R, Robertson HA (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci U S A 87:6912–6916PubMedPubMedCentralCrossRefGoogle Scholar
  17. Hamamura M, Ozawa H, Kimuro Y, Okouchi J, Higasa K, Iwaki A, Fukumaki Y (1999) Differential decreases in c-fos and aldolase C mRNA expression in the rat cerebellum afterrepeated administration of methamphetamine. Brain Res Mol Brain Res 64:119–31PubMedCrossRefGoogle Scholar
  18. Hashimoto K, Suemaru S, Takao T, Sugawara M, Makino S, Ota Z (1988) Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats. Regul Pept 23:117–126PubMedCrossRefGoogle Scholar
  19. Hauger RL, Millan MA, Lorang M, Harwood JP, Aguilera G (1988) Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology 123:396–405PubMedCrossRefGoogle Scholar
  20. Hildebrandt T, Greif R (2013) Stress and addiction. Psychoneuroendocrinology 38:1923–1927PubMedPubMedCentralCrossRefGoogle Scholar
  21. Hope B, Kosofsky B, Hyman SE, Nestler EJ (1992) Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci U S A 89:5764–8PubMedPubMedCentralCrossRefGoogle Scholar
  22. Inenaga K, Osaka T, Yamashita H (1987) Thermosensitivity of neurons in the paraventricular nucleus of the rat slice preparation. Brain Res 424:126–32PubMedCrossRefGoogle Scholar
  23. Jang CG, Whitfield T, Schulteis G, Koob GF, Wee S (2013) A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats. Psychopharmacology (Berl) 225:753–763CrossRefGoogle Scholar
  24. Jedynak JP, Cameron CM, Robinson TE (2012) Repeated methamphetamine administration differentially alters fos expression in caudate-putamen patch and matrix compartments and nucleus accumbens. PLoS ONE 7, e34227PubMedPubMedCentralCrossRefGoogle Scholar
  25. Jian M, Luo YX, Xue YX, Han Y, Shi HS, Liu JF, Yan W, Wu P, Meng SQ, Deng JH, Shen HW, Shi J, Lu L (2014) eIF2α dephosphorylation in basolateral amygdala mediates reconsolidation of drug memory. J Neurosci 34:10010–10021PubMedCrossRefGoogle Scholar
  26. Johnson LA, Olsen RH, Merkens LS, DeBarber A, Steiner RD, Sullivan PM, Maeda N, Raber J (2014) Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol Dis 64:150–162PubMedPubMedCentralCrossRefGoogle Scholar
  27. Justice NJ, Yuan ZF, Sawchenko PE, Vale W (2008) Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system. J Comp Neurol 511:479–496PubMedPubMedCentralCrossRefGoogle Scholar
  28. Kabbaj M, Yoshida S, Numachi Y, Matsuoka H, Devine DP, Sato M (2003) Methamphetamine differentially regulates hippocampal glucocorticoid and mineralocorticoid receptor mRNAs in Fischer and Lewis rats. Brain Res Mol Brain Res 117:8–14PubMedCrossRefGoogle Scholar
  29. Kalechstein AD, Newton TF, Green M (2003) Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 15:215–220PubMedCrossRefGoogle Scholar
  30. Li SX, Yan SY, Bao YP, Lian Z, Qu Z, Wu YP, Liu ZM (2013) Depression and alterations in hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis function in male abstinent methamphetamine abusers. Hum Psychopharmacol 28:477–483PubMedCrossRefGoogle Scholar
  31. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W (2004) Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 61:73–84PubMedCrossRefGoogle Scholar
  32. Lowy MT (1990) MK-801 antagonizes methamphetamine-induced decreases in hippocampal and striatal corticosteroid receptors. Brain Res 533:348–52PubMedCrossRefGoogle Scholar
  33. Martin TA, Jayanthi S, McCoy MT, Brannock C, Ladenheim B, Garrett T, Lehrmann E, Becker KG, Cadet JL (2012) Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation/hypoacetylation in the rat nucleus accumbens. PLoS ONE 7, e34236PubMedPubMedCentralCrossRefGoogle Scholar
  34. McCoy MT, Jayanthi S, Wulu JA, Beauvais G, Ladenheim B, Martin TA, Krasnova IN, Hodges AB, Cadet JL (2011) Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection. Psychopharmacology (Berl) 215:353–365PubMedCentralCrossRefGoogle Scholar
  35. Melia KR, Ryabinin AE, Schroeder R, Bloom FE, Wilson MC (1994) Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J Neurosci 14:5929–5938PubMedGoogle Scholar
  36. Moffett MC, Goeders NE (2007) CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats. Psychopharmacology (Berl) 190:171–180CrossRefGoogle Scholar
  37. Moratalla R, Robertson HA, Graybiel AM (1992) Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J Neurosci 12:2609–2622PubMedGoogle Scholar
  38. Myles BJ, Sabol KE (2008) The effects of methamphetamine on core body temperature in the rat--part 2: an escalating regimen. Psychopharmacology (Berl) 198:313–322CrossRefGoogle Scholar
  39. Myles BJ, Jarrett LA, Broom SL, Speaker HA, Sabol KE (2008) The effects of methamphetamine on core body temperature in the rat--part 1: chronic treatment and ambient temperature. Psychopharmacology (Berl) 198:301–311CrossRefGoogle Scholar
  40. Nawata Y, Kitaichi K, Yamamoto T (2012) Increases of CRF in the amygdala are responsible for reinstatement of methamphetamine-seeking behavior induced by footshock. Pharmacol Biochem Behav 10:297–302CrossRefGoogle Scholar
  41. Pham K, Nacher J, Hof PR, McEwen BS (2003) Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci 17(4):879–86PubMedCrossRefGoogle Scholar
  42. Raber J (1998) Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits. Mol Neurobiol 18:1–22PubMedCrossRefGoogle Scholar
  43. Reichel CM, Schwendt M, McGinty JF, Olive MF, See RE (2011) Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 36:782–92PubMedPubMedCentralCrossRefGoogle Scholar
  44. Reichel CM, Ramsey LA, Schwendt M, McGinty JF, See RE (2012) Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 62:1119–1126PubMedPubMedCentralCrossRefGoogle Scholar
  45. Rendell PG, Mazur M, Henry JD (2009) Prospective memory impairment in former users of methamphetamine. Psychopharmacology (Berl) 203:609–16CrossRefGoogle Scholar
  46. Santos TB, Céspedes IC, Viana MB (2014) Chronic corticosterone administration facilitates aversive memory retrieval and increases GR/NOS immunoreactivity. Behav Brain Res 267:46–54PubMedCrossRefGoogle Scholar
  47. Shoener JA, Baig R, Page KC (2006) Prenatal exposure to dexamethasone alters hippocampal drive on hypothalamic-pituitary-adrenal axis activity in adult male rats. Am J Physiol Regul Integr Comp Physiol 290:1366–1373CrossRefGoogle Scholar
  48. Silva CD, Neves AF, Dias AI, Freitas HJ, Mendes SM, Pita I, Viana SD, de Oliveira PA, Cunha RA, Fontes Ribeiro CA, Prediger RD, Pereira FC (2014) A single neurotoxic dose of methamphetamine induces a long-lasting depressive-like behaviour in mice. Neurotox Res 25:295–304PubMedCrossRefGoogle Scholar
  49. Stephan FK, Nunez AA (1977) Elimination of circadian rhythms in drinking, activity, sleep, and temperature by isolation of the suprachiasmatic nuclei. Behav Biol 20:1–61PubMedCrossRefGoogle Scholar
  50. Substance Abuse and Mental Health Services Administration (SAMHSA) (2012) Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. In: NSDUH Series H-44, HHS Publication No. (SMA) 12–4713. Substance Abuse and Mental Health Services Administration, Rockville, MDGoogle Scholar
  51. Umemoto S, Noguchi K, Kawai Y, Senba E (1994) Repeated stress reduces the subsequent stress-induced expression of Fos in rat brain. Neurosci Lett 167:101–104PubMedCrossRefGoogle Scholar
  52. Uno H, Tarara R, Else JG, Suleman MA, Sapolsky RM (1989) (1989) Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 9(5):1705–1711PubMedGoogle Scholar
  53. Zahm DS, Becker ML, Freiman AJ, Strauch S, Degarmo B, Geisler S, Meredith GE, Marinelli M (2010) Fos after single and repeated self-administration of cocaine and saline in the rat: emphasis on the Basal forebrain and recalibration of expression. Neuropsychopharmacology 35:445–63PubMedPubMedCentralCrossRefGoogle Scholar
  54. Zaretskaia MV, Zaretsky DV, Shekhar A, DiMicco JA (2002) Chemical stimulation of the dorsomedial hypothalamus evokes non-shivering thermogenesis in anesthetized rats. Brain Res 928:113–125PubMedCrossRefGoogle Scholar
  55. Zhang J, Zhang L, Jiao H, Zhang Q, Zhang D, Lou D, Katz JL, Xu M (2006) c-Fos facilitates the acquisition and extinction of cocaine-induced persistent changes. J Neurosci 26:13287–13296PubMedCrossRefGoogle Scholar
  56. Zhu H, Mingler MK, McBride ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Williams MT, Vorhees CV, Rothenberg ME (2010) Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1. Psychoneuroendocrinology 35:1119–1132PubMedPubMedCentralCrossRefGoogle Scholar
  57. Zorrilla EP, Heilig M, de Wit H, Shaham Y (2013) Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend 128:175–86PubMedPubMedCentralCrossRefGoogle Scholar
  58. Zuloaga DG, Siegel JA, Acevedo SF, Agam M, Raber J (2013) Developmental methamphetamine exposure results in short- and long-term alterations in hypothalamic-pituitary-adrenal-axis-associated proteins. Dev Neurosci 35:338–346PubMedCrossRefGoogle Scholar
  59. Zuloaga DG, Johnson LA, Agam M, Raber J (2014) Sex differences in activation of the hypothalamic-pituitary-adrenal axis by methamphetamine. J Neurochem 129:495–508PubMedPubMedCentralCrossRefGoogle Scholar
  60. Zuloaga DG, Iancu O, Weber S, Etzel D, Marzulla T, Stewart B, Allen CN, Raber J (2015a) Enhanced functional connectivity involving the ventromedial hypothalamus following methamphetamine exposure. Front Neurosci 9:326Google Scholar
  61. Zuloaga DG, Jacobskind JS, Raber J (2015b) Methamphetamine and the hypothalamic-pituitary-adrenal axis. Front Neurosci 9:178PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Damian G. Zuloaga
    • 1
    • 2
  • Lance A. Johnson
    • 1
  • Sydney Weber
    • 1
  • Jacob Raber
    • 1
    • 3
    • 4
    • 5
  1. 1.Department of Behavioral NeuroscienceOregon Health and Science University PortlandPortlandUSA
  2. 2.Department of PsychologyUniversity at AlbanyAlbanyUSA
  3. 3.Department of NeurologyOregon Health and Science University PortlandPortlandUSA
  4. 4.Department of Radiation MedicineOregon Health and Science University PortlandPortlandUSA
  5. 5.Division of Neuroscience, ONPRCOregon Health and Science University PortlandPortlandUSA

Personalised recommendations